vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Howard Hughes Holdings Inc. (HHH). Click either name above to swap in a different company.
Howard Hughes Holdings Inc. is the larger business by last-quarter revenue ($624.4M vs $359.9M, roughly 1.7× AdvanSix Inc.). Howard Hughes Holdings Inc. runs the higher net margin — 1.0% vs -0.8%, a 1.7% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs -33.2%). Howard Hughes Holdings Inc. produced more free cash flow last quarter ($348.6M vs $36.1M). Over the past eight quarters, Howard Hughes Holdings Inc.'s revenue compounded faster (91.0% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Howard Hughes Holdings Inc., formerly the Howard Hughes Corporation, is a real estate development and management company based in The Woodlands, Texas. It was formed in 2010 as a spin-off from General Growth Properties (GGP). Most of its holdings are focused on several master-planned communities. It took its name from the original Howard Hughes Corporation, which had developed the planned community of Summerlin, Nevada, and later became a subsidiary of GGP.
ASIX vs HHH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $624.4M |
| Net Profit | $-2.8M | $6.0M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | 4.2% |
| Net Margin | -0.8% | 1.0% |
| Revenue YoY | 9.4% | -33.2% |
| Net Profit YoY | -892.9% | -96.2% |
| EPS (diluted) | $-0.11 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $624.4M | ||
| Q3 25 | $374.5M | $390.2M | ||
| Q2 25 | $410.0M | $260.9M | ||
| Q1 25 | $377.8M | $199.3M | ||
| Q4 24 | $329.1M | $935.0M | ||
| Q3 24 | $398.2M | $327.1M | ||
| Q2 24 | $453.5M | $317.4M | ||
| Q1 24 | $336.8M | $171.1M |
| Q4 25 | $-2.8M | $6.0M | ||
| Q3 25 | $-2.6M | $119.5M | ||
| Q2 25 | $31.4M | $-12.1M | ||
| Q1 25 | $23.3M | $10.5M | ||
| Q4 24 | $352.0K | $156.3M | ||
| Q3 24 | $22.3M | $72.8M | ||
| Q2 24 | $38.9M | $21.1M | ||
| Q1 24 | $-17.4M | $-52.5M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | 4.2% | ||
| Q3 25 | -0.9% | 48.6% | ||
| Q2 25 | 7.7% | 26.0% | ||
| Q1 25 | 7.7% | 24.0% | ||
| Q4 24 | -3.9% | 33.5% | ||
| Q3 24 | 7.5% | 60.6% | ||
| Q2 24 | 11.5% | 20.4% | ||
| Q1 24 | -7.0% | -9.8% |
| Q4 25 | -0.8% | 1.0% | ||
| Q3 25 | -0.7% | 30.6% | ||
| Q2 25 | 7.7% | -4.7% | ||
| Q1 25 | 6.2% | 5.3% | ||
| Q4 24 | 0.1% | 16.7% | ||
| Q3 24 | 5.6% | 22.2% | ||
| Q2 24 | 8.6% | 6.6% | ||
| Q1 24 | -5.2% | -30.7% |
| Q4 25 | $-0.11 | $0.20 | ||
| Q3 25 | $-0.10 | $2.02 | ||
| Q2 25 | $1.15 | $-0.22 | ||
| Q1 25 | $0.86 | $0.21 | ||
| Q4 24 | $0.02 | $3.14 | ||
| Q3 24 | $0.82 | $1.46 | ||
| Q2 24 | $1.43 | $0.42 | ||
| Q1 24 | $-0.65 | $-1.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $1.5B |
| Total DebtLower is stronger | — | $5.1B |
| Stockholders' EquityBook value | $815.2M | $3.8B |
| Total Assets | $1.7B | $10.6B |
| Debt / EquityLower = less leverage | — | 1.35× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $1.5B | ||
| Q3 25 | $23.7M | $1.5B | ||
| Q2 25 | $18.4M | $1.4B | ||
| Q1 25 | $8.3M | $493.7M | ||
| Q4 24 | $19.6M | $596.1M | ||
| Q3 24 | $17.3M | $400.7M | ||
| Q2 24 | $12.1M | $436.8M | ||
| Q1 24 | $20.6M | $462.7M |
| Q4 25 | — | $5.1B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $5.1B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $815.2M | $3.8B | ||
| Q3 25 | $818.2M | $3.8B | ||
| Q2 25 | $823.7M | $3.6B | ||
| Q1 25 | $794.4M | $2.8B | ||
| Q4 24 | $774.6M | $2.8B | ||
| Q3 24 | $766.4M | $2.6B | ||
| Q2 24 | $746.6M | $3.0B | ||
| Q1 24 | $713.2M | $2.9B |
| Q4 25 | $1.7B | $10.6B | ||
| Q3 25 | $1.7B | $10.7B | ||
| Q2 25 | $1.6B | $10.3B | ||
| Q1 25 | $1.6B | $9.3B | ||
| Q4 24 | $1.6B | $9.2B | ||
| Q3 24 | $1.5B | $9.4B | ||
| Q2 24 | $1.5B | $9.9B | ||
| Q1 24 | $1.5B | $9.6B |
| Q4 25 | — | 1.35× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.85× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $360.3M |
| Free Cash FlowOCF − Capex | $36.1M | $348.6M |
| FCF MarginFCF / Revenue | 10.0% | 55.8% |
| Capex IntensityCapex / Revenue | 7.7% | 1.9% |
| Cash ConversionOCF / Net Profit | — | 60.04× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $417.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $360.3M | ||
| Q3 25 | $26.6M | $149.8M | ||
| Q2 25 | $21.1M | $177.3M | ||
| Q1 25 | $11.4M | $-224.9M | ||
| Q4 24 | $64.2M | $337.1M | ||
| Q3 24 | $57.3M | $248.3M | ||
| Q2 24 | $50.2M | $-17.5M | ||
| Q1 24 | $-36.2M | $-171.2M |
| Q4 25 | $36.1M | $348.6M | ||
| Q3 25 | $66.0K | $137.7M | ||
| Q2 25 | $-7.2M | $169.7M | ||
| Q1 25 | $-22.6M | $-238.4M | ||
| Q4 24 | $29.8M | $317.1M | ||
| Q3 24 | $26.8M | $238.7M | ||
| Q2 24 | $16.7M | $-25.1M | ||
| Q1 24 | $-71.6M | $-182.0M |
| Q4 25 | 10.0% | 55.8% | ||
| Q3 25 | 0.0% | 35.3% | ||
| Q2 25 | -1.7% | 65.1% | ||
| Q1 25 | -6.0% | -119.6% | ||
| Q4 24 | 9.1% | 33.9% | ||
| Q3 24 | 6.7% | 73.0% | ||
| Q2 24 | 3.7% | -7.9% | ||
| Q1 24 | -21.3% | -106.4% |
| Q4 25 | 7.7% | 1.9% | ||
| Q3 25 | 7.1% | 3.1% | ||
| Q2 25 | 6.9% | 2.9% | ||
| Q1 25 | 9.0% | 6.8% | ||
| Q4 24 | 10.4% | 2.1% | ||
| Q3 24 | 7.7% | 2.9% | ||
| Q2 24 | 7.4% | 2.4% | ||
| Q1 24 | 10.5% | 6.3% |
| Q4 25 | — | 60.04× | ||
| Q3 25 | — | 1.25× | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.49× | -21.35× | ||
| Q4 24 | 182.29× | 2.16× | ||
| Q3 24 | 2.57× | 3.41× | ||
| Q2 24 | 1.29× | -0.83× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
HHH
| Transferred At Point In Time | $499.8M | 80% |
| Operating Assets Segment | $117.9M | 19% |
| Builder Price Participation | $12.9M | 2% |
